Frequency of Thalassemia, Iron and Glucose-6Phosphate Dehydrogenase Deficiency Among Turkish Migrating Nomad Children in Southern Iran
Abstract
Ferropenia and consequent iron deficiency anemia (IDA), β-thalassemia, and glucose 6-phosphate dehydrogenase (G6PD) deficiency are three main common hematological problems in Iran. This study was conducted to investigate the prevalence of these problems in Turkish migrating nomads in southern Iran. From June to October 2006, the blood sample of 152 Turkish migrating nomadic children including 79 (52%) males and 73 (48%) females were evaluated for iron indices and G6PD deficiency in southern Iran. The family history of thalassemia, favism, and signs and symptoms related to anemia of participants were determined. RBC count, different types of Hb, Hct, MCV, MCH, MCHC, RDW, SI, TIBC and SF were measured immediately after blood sampling. Twenty-seven (17.7%) children had serum ferritin (SF) level <12 ng/dL, while this low serum ferritin level was similar in both genders. The low hemoglobin (Hb) level had a statistical correlation with the low serum ferritin level. Among all participants, the prevalence of G6PD deficiency was 7.2% which was more frequent in males compared to females (8.9% vs. 5.5%). Seven (4.6%) children had Hb 3.5 g/dL; and the prevalence of β-thalassemia trait was higher in female children compared with males (5.5% vs. 3.8%). The prevalence of IDA was 17.7%. Although this figure is less than the prevalence found in other developing countries (25-35%); but it shows that Turkish ethnic nomads in southern Iran are still behind the health statues in the industrialized countries (5-8%). The relatively high prevalence of β-thalassemia trait also is a major potential risk; and careful performance of Iranian thalassaemia program is highly suggested. It seems that G6PD deficiency is a prevalent disease in migrating Turkish nomads, and again establishment of educational programs, and investigation of dietary habits of Turkish migrating nomads on how and by whom the fava beans are consumed; seems to be a good way to prevent favism.
Farhud D, Sadighi H. Investigation of prevalence of thalassemia in Iran. Iran J Pubic Health 1997; 26: 1-2.
Nasab AH. Clinical and laboratory findings in the initial diagnosis of homozygous beta thalassemia on fars province, Iran. Br J Haematol 1979; 43(1): 57-61.
Alebouyeh M. Pediatric hematology and oncology in Iran. Pediatr Hematol Oncol 2005; 22(1): 1-9.
Caro JJ, Ward A, Green TC, Huybrechts K, Arana A, Wait S, et al. Impact of thalassemia major on patients and their families. Acta Haematol 2002; 107(3): 150-7.
Noori-Daloii MR, Moazami N, Farhangi S, Atalay A, Geren IN, Akar L, et al. Beta-thalassemia in Iran: a high incidence of the nonsense codon 39 mutation on the island of Queshm. Hemoglobin 1994; 18(6): 449-53.
Karimi M, Yarmohammadi H, Farjadian S, Zeinali S, Moghaddam Z, Cappellini MD, et al. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G-->A) is the prevalent thalassemia intermedia allele. Hemoglobin 2002; 26(2): 147-54.
Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of beta-thalassemia in the Iranian Province of Hormozgan. Hemoglobin 2001; 25(1): 35-43.
Neishabury M, Oberkanins C, Moheb LA, Pourfatholuah AA, Kahrizi K, Keyhany E, et al. High prevalence of the - alpha3.7 deletion among thalassemia patients in Iran. Hemoglobin 2003; 27(1): 53-5.
Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ 2004; 329(7475): 1134-7.
Kazal LA Jr. Prevention of iron deficiency anemia in infants and toddlers. Am Fam Physician 2002; 66(7): 1217-24.
Hedayat S, Rahbar S, Mahboobi E, Ghaffarpour M, Sobhi N. Favism in the Caspian littoral area of Iran. Trop Geogr Med 1971; 23(2): 149-57.
Donoso G, Hedayat H, Khayatian H. Favism, with special reference to Iran. Bull World Health Organ 1969; 40(4): 513-9.
Wolf BH, Weening RS, Schutgens RB, Van Noorden CJ, Vogels IM, Nagelkerke NJ. Detection of glucose 6- Phosphate dehydrogenase deficiency in erythrocytes: A spectrophotometric assay and a fluorescent spot test compared with a cytochemical method. Clin Chim Acata 1987; 168(2): 129-36.
The laboratory diagnosis of haemoglobinopathies [editorial]. Br J Haematol 1998; 101(4): 783-92.
DeMaeyer EM, Dallman P, Gurney JM, Hallberg L, Sood SK, Srikantia SG. Preventing and controlling iron deficiency anemia through primary health care. A guide for health administrators and programme managers. Geneva, Switzerland, World Health Organization, 1989.
Milman N. Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 1996; 63(2): 103-35.
Kadivar MR, Yarmohammadi H, Mirahmadizadeh AR, Vakili M, Karimi M. Prevalence of iron deficiency anemia in 6 months to 5 years old children in fars. Southern Iran. Med Sci Monit 2003; 9(2): CR100-4.
Karimi M, Kadivar MR, Yarmohammadi H. Assesment of the prevalence of iron deficiency anemia, by serum ferritin, in pregnant women of southern Iran. Med Sci Monit 2002; 8(7): CR488-92.
Jain S, Chopra H, Garg SK, Bhatnagar M, Singh JV. Anemia in children: early iron supplementation. Indian J Pediatr 2000; 67(1): 19-21.
Caballo Roig N, García P, Valdemoro M, del Castillo ML, Santos Tapia M, González Vargaz A, et al. The prevalence of anemia in the children and adolescents of Madrid. An Esp Pediatr 1993; 39(3): 219-22.
Lapeyssonnie L, Keyhan R. Proceedings of the first seminar of favism in Iran, Tehran, Food and Nutrition Institute of Iran: 1966; 36.
Ohkura K, Miyashita T, Nakajima H, Matsumoto H, Matsutomo K, Rahabar S, et al. Distribution of polymorphic traits in Mazandaranian and Guilanian in Iran. Hum Hered 1984; 34(1): 27-39.
Elton P. Learning from low income countries: Thalassaemia screening in Iran provides evidence for programme in Lancashire. BMJ 2005; 330(7489): 478; discussion 479.
Christanson A, Streetly A, Darr A. Lessons from thalassemia screening in Iran. BMJ 2004; 329(7475): 1115-7.
Zakerinia M, Khojasteh HN, Ramzi M, Amirghofran Z, Tabei Z, Haghshenas M. Bone marrow transplantation for thalassemia in Shiraz. Transplant Proc 1995; 27(5): 2659-60.
Ramzi M, Nourani H, Zakerinia M, Hamidian Jahromi AR. Hematopoietic stem cell transplantation for betathalassemia major: Experience in south of Iran. Transplant Proc 2004; 36(8): 2509-10.
Khojasteh NH, Zakerinia M, Ramzi M, Haghshenas M. Results of allogeneic bone marrow transplantation in 90 patients at a University Hospital in Southern Iran. Transplant Proc 2000; 32(3): 597.
Lapeyssonnie L, Keyhan R. Proceedings of the first seminarof favism in Iran, Tehran, Food and Nutrition Institute of Iran: 1966; 36.
Ohkura K, Miyashita T, Nakajima H, Matsumoto H, Matsutomo K, Rahabar S, Hedayat S. Distribution of polymorphic traits in Mazandaranean and Guillanian in Iran. Hum Hered. 1984; 34: 27-39.
Elton P. Learning from low income countries: Thalassaemia screening in Iran provides evidence for programme inLancashire. Br Med J. 2005; 330(7489): 478-479.
Christanson A, Streetly A, Darr A. Lessons from thalassemia screening in Iran. Br Med J. 2004; 329(7475): 1115-7.
Zakerinia M, Khojasteh HN, Ramzi M, Amirghafran Z, Tabei Z, Haghshenas M. Bone marrow transplantation for thalassemia in Shiraz. Transplant Proc. 1995; 27(5): 2659-60.
Ramzi M, Nourani H, Zakerinia M, Hamidian Jahromi AR. Hematopoietic stem cell transplantation for betathalassemia major: Experience in south of Iran. Transplant Proc. 2004; 36(8): 2509-10.
Khojasteh HN, Zakerinia M, Ramzi M, Haghshenas M. Results of allogeneic bone marrow transplantation in 90 patients at a University Hospital in southern Iran. Transplant Proc. 2000; 32(3): 597.
Files | ||
Issue | Vol 47, No 1 (2009) | |
Section | Articles | |
Keywords | ||
Iron deficiency thalassemia G6PD deficiency nomads southern Iran |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |